Cefuroxime Sodium
NDC Package 66288-2075-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Cefuroxime Sodium is cefuroxime is used to treat a wide variety of bacterial infections. Marketed by Samson Medical Technologies, L.l.c., this product is identified by NDC 66288-2075 and is authorized under FDA application ANDA065251.

Identification & Billing

NDC Package Code
66288-2075-1
Package Description
1 INJECTION, POWDER, FOR SOLUTION in 1 BAG
Product Code
66288-2075
11-Digit Billing Format
66288207501
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
1 EA

Clinical Specifications

Proprietary Name
Cefuroxime Sodium
Dosage Form
-
Usage Information
Cefuroxime is used to treat a wide variety of bacterial infections. It may also be used to prevent infection from certain surgeries. This medication belongs to a class of drugs known as cephalosporin antibiotics. It works by stopping the growth of bacteria.

Regulatory & Marketing

Labeler Name
Samson Medical Technologies, L.l.c.
FDA Application #
ANDA065251
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
02-01-2010
End Marketing Date
09-01-2013
Listing Expiration
09-01-2013
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 66288-2075-1 identifies a specific commercial package of 1 injection, powder, for solution in 1 bag of Cefuroxime Sodium, labeled by Samson Medical Technologies, L.l.c.. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Samson Medical Technologies, L.l.c. on February 01, 2010. The current certification is valid through September 01, 2013.

What are the primary indications for this medication?

Cefuroxime is used to treat a wide variety of bacterial infections. It may also be used to prevent infection from certain surgeries. This medication belongs to a class of drugs known as cephalosporin antibiotics. It works by stopping the growth of bacteria.

How is this Samson Medical Technologies, L.l.c. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 66288207501. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
66288-2075-1
11-Digit CMS (5-4-2)
66288-2075-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.